Credelio PLUS

Credelio PLUS is a leading prescription parasite protection brand owned and manufactured by the global animal health company Elanco. The brand offers a range of monthly chewable tablets that provide comprehensive coverage against fleas, ticks including the deadly paralysis tick, heartworm, and intestinal worms.

Their formula combines two active ingredients, lotilaner and milbemycin oxime, to deliver fast-acting and long-lasting protection in what is marketed as the smallest four-in-one chew available. As a core product in the Elanco portfolio, which significantly expanded following the acquisition of Bayer Animal Health in 2020, Credelio PLUS is a major competitor in the broad-spectrum preventative market.

The range is ideal for owners researching small, palatable oral treatments that are safe for puppies from eight weeks of age and at least 2.8kg in weight.